248 related articles for article (PubMed ID: 8740453)
21. Modulation of NMDA receptor function by ketamine and magnesium: Part I.
Liu HT; Hollmann MW; Liu WH; Hoenemann CW; Durieux ME
Anesth Analg; 2001 May; 92(5):1173-81. PubMed ID: 11323343
[TBL] [Abstract][Full Text] [Related]
22. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
23. Heteromeric NMDA receptors: molecular and functional distinction of subtypes.
Monyer H; Sprengel R; Schoepfer R; Herb A; Higuchi M; Lomeli H; Burnashev N; Sakmann B; Seeburg PH
Science; 1992 May; 256(5060):1217-21. PubMed ID: 1350383
[TBL] [Abstract][Full Text] [Related]
24. N-acetylaspartylglutamate acts as an agonist upon homomeric NMDA receptor (NMDAR1) expressed in Xenopus oocytes.
Sekiguchi M; Wada K; Wenthold RJ
FEBS Lett; 1992 Oct; 311(3):285-9. PubMed ID: 1356833
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements.
Hansen KB; Bräuner-Osborne H; Egebjerg J
Comb Chem High Throughput Screen; 2008 May; 11(4):304-15. PubMed ID: 18473740
[TBL] [Abstract][Full Text] [Related]
26. Ethanol sensitivity of heteromeric NMDA receptors: effects of subunit assembly, glycine and NMDAR1 Mg(2+)-insensitive mutants.
Mirshahi T; Woodward JJ
Neuropharmacology; 1995 Mar; 34(3):347-55. PubMed ID: 7630488
[TBL] [Abstract][Full Text] [Related]
27. Specificity of putative partial agonist, 1-aminocyclopropanecarboxylic acid, for rat N-methyl-D-aspartate receptor subunits.
Sheinin A; Nahum-Levy R; Shavit S; Benveniste M
Neurosci Lett; 2002 Jan; 317(2):77-80. PubMed ID: 11755244
[TBL] [Abstract][Full Text] [Related]
28. Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine.
Sheinin A; Shavit S; Benveniste M
Neuropharmacology; 2001 Aug; 41(2):151-8. PubMed ID: 11489451
[TBL] [Abstract][Full Text] [Related]
29. Subunit-dependent inhibition of recombinant rodent N-methyl-D-aspartate receptors by a HIV-1 glycoprotein 120 derived peptide.
Wittekindt B; Betz H; Laube B
Neurosci Lett; 2000 Feb; 280(2):151-4. PubMed ID: 10686400
[TBL] [Abstract][Full Text] [Related]
30. Subunit-specific block of cloned NMDA receptors by argiotoxin636.
Raditsch M; Ruppersberg JP; Kuner T; Günther W; Schoepfer R; Seeburg PH; Jahn W; Witzemann V
FEBS Lett; 1993 Jun; 324(1):63-6. PubMed ID: 8099331
[TBL] [Abstract][Full Text] [Related]
31. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
32. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics.
Hollmann MW; Liu HT; Hoenemann CW; Liu WH; Durieux ME
Anesth Analg; 2001 May; 92(5):1182-91. PubMed ID: 11323344
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
Williams K; Zappia AM; Pritchett DB; Shen YM; Molinoff PB
Mol Pharmacol; 1994 May; 45(5):803-9. PubMed ID: 8190097
[TBL] [Abstract][Full Text] [Related]
34. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
35. Ethanol inhibits glutamate-induced currents in heteromeric NMDA receptor subtypes.
Kuner T; Schoepfer R; Korpi ER
Neuroreport; 1993 Dec; 5(3):297-300. PubMed ID: 7905294
[TBL] [Abstract][Full Text] [Related]
36. Transfer of NMDAR2 cDNAs increases endogenous NMDAR1 protein and induces expression of functional NMDA receptors in PC12 cells.
Saito Y; Tsuzuki K; Yamada N; Okado H; Miwa A; Goto F; Ozawa S
Brain Res Mol Brain Res; 2003 Feb; 110(2):159-68. PubMed ID: 12591153
[TBL] [Abstract][Full Text] [Related]
37. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
Chen PE; Geballe MT; Katz E; Erreger K; Livesey MR; O'Toole KK; Le P; Lee CJ; Snyder JP; Traynelis SF; Wyllie DJ
J Physiol; 2008 Jan; 586(1):227-45. PubMed ID: 17962328
[TBL] [Abstract][Full Text] [Related]
38. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
Williams K
Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335
[TBL] [Abstract][Full Text] [Related]
39. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
Erreger K; Geballe MT; Kristensen A; Chen PE; Hansen KB; Lee CJ; Yuan H; Le P; Lyuboslavsky PN; Micale N; Jørgensen L; Clausen RP; Wyllie DJ; Snyder JP; Traynelis SF
Mol Pharmacol; 2007 Oct; 72(4):907-20. PubMed ID: 17622578
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a tetrameric structure of recombinant NMDA receptors.
Laube B; Kuhse J; Betz H
J Neurosci; 1998 Apr; 18(8):2954-61. PubMed ID: 9526012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
